RPR109881
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RPR109881, covering 2008-08-21 to 2009-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment [Phase 2]